This proposal investigates the ontogeny of basophils and mast cells, a high priority search area listed in the FOA. Basophils and mast cells are important components of type 2 immune responses, which cause allergic diseases and provide immune protection against parasitic infections. The incidence of allergic diseases, such as anaphylaxis, allergic rhinitis, atopic dermatitis, food allergy and asthma, has tripled in the Western countries since the 1980s. Hundreds of millions of people in the developing world are infected with helminth parasites. How basophils and mast cells develop into cells with specialized functions remains poorly understood. We have identified a novel population of common basophil-mast cell progenitors in the bone marrow. We have identified C/EBP? as the critical basophil transcription factor for specifying basophil cell fate and MITF as the crucial transcription factor for specifying mast cell fate. We demonstrate that transcription factor GATA2 is an upstream regulator of the Mitf and Cebpa genes. We found that MXD1 is a critical C/EBP? downstream transcription factor that might be important in basophil development and function, whereas BHLHE40 and AHRR are crucial MITF downstream transcription factors that might be important in mast cell development and function. Based on our preliminary analyses, we hypothesize that GATA2 upregulates the Mitf or Cebpa gene expression stochastically during the differentiation of pre-BMPs into basophils or mast cells and C/EBP?- dependent MXD1 plays a critical role in basophil development, whereas MITF-dependent BHLHE40 is crucial in mast cell development. We will test these hypotheses in 3 aims.
In aim 1, we will analyze how GATA2 regulates the expression of the master basophil transcription factor C/EBP? gene and master mast cell transcription factor Mitf gene to specify the basophil and mast cell fates.
In Aim 2, we will analyze the role of MXD1 in basophil development and function.
In Aim 3, we will define the role of BHLHE40 and AHRR in MC development and function. Our grant proposal through innovative approaches will generate novel concepts and will significantly advance our understanding of how type 2 innate effector cells develop at the molecular level. The advancements in understanding basophil and mast cell fate determination is a critical concept, which must be better understood before subsequent studies to develop new treatment strategies or preventative methods for food allergy can be undertaken.

Public Health Relevance

This proposal investigates the ontogeny of basophils and mast cells. We will determine the mechanism of how transcription factor GATA2 specifies basophil versus mast cell fate and how the downstream transcription factors C/EBP?-dependent MXD1 and MITF- dependent BHLHE40 and AHRR regulate basophil and mast cell development and function

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI107022-03
Application #
9388299
Study Section
Cellular and Molecular Immunology - A Study Section (CMIA)
Program Officer
Jiang, Chao
Project Start
2015-12-01
Project End
2020-11-30
Budget Start
2017-12-01
Budget End
2018-11-30
Support Year
3
Fiscal Year
2018
Total Cost
Indirect Cost
Name
National Jewish Health
Department
Type
DUNS #
076443019
City
Denver
State
CO
Country
United States
Zip Code
80206
Li, Yapeng; Liu, Bing; Harmacek, Laura et al. (2018) The transcription factors GATA2 and microphthalmia-associated transcription factor regulate Hdc gene expression in mast cells and are required for IgE/mast cell-mediated anaphylaxis. J Allergy Clin Immunol 142:1173-1184
Huang, Hua; Li, Yapeng; Liang, Jinyi et al. (2018) Molecular Regulation of Histamine Synthesis. Front Immunol 9:1392
Huang, Hua; Li, Yapeng; Liu, Bing (2016) Transcriptional regulation of mast cell and basophil lineage commitment. Semin Immunopathol 38:539-48
Huang, Yafei; Getahun, Andrew; Heiser, Ryan A et al. (2016) ?? T Cells Shape Preimmune Peripheral B Cell Populations. J Immunol 196:217-31